Knowledge Hub

Toray Industries, Inc. - Product Pipeline Review - 2016

Press release   •   Nov 29, 2016 04:43 EST has recently announced the addition of a market study “ Toray Industries, Inc. - Product Pipeline Review - 2016”, is a comparative analysis of the global market.

Toray Industries, Inc. - Product Pipeline Review - 2016


Global Markets Directs, Toray Industries, Inc. - Product Pipeline Review - 2016, provides an overview of the Toray Industries, Inc.s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Toray Industries, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.


- The report provides a snapshot of the pipeline therapeutic landscape of Toray Industries, Inc.

- The report provides overview of Toray Industries, Inc. including its business description, key facts, and locations and subsidiaries

- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

- The report assesses Toray Industries, Inc.s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

- The report features Toray Industries, Inc.s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Download The sample Copy Of This Report:

Reasons to buy

- Evaluate Toray Industries, Inc.s strategic position with total access to detailed information on its product pipeline

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of therapeutics under development for Toray Industries, Inc.

- Identify potential new clients or partners in the target demographic

- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics

- Devise corrective measures for pipeline projects by understanding Toray Industries, Inc.s pipeline depth and focus of pipeline therapeutics

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table Of Content

Table of Contents 2

List of Tables 4

List of Figures 4

Toray Industries, Inc. Snapshot 5

Toray Industries, Inc. Overview 5

Key Facts 5

Toray Industries, Inc. - Research and Development Overview 6

Key Therapeutic Areas 6

Toray Industries, Inc. - Pipeline Review 8

Pipeline Products by Stage of Development 8

Pipeline Products - Monotherapy 9

Pipeline Products - Partnered Products 10

Partnered Products/Combination Treatment Modalities 11

Pipeline Products - Out-Licensed Products 12

Out-Licensed Products/Combination Treatment Modalities 13

Toray Industries, Inc. - Pipeline Products Glance 14

Toray Industries, Inc. - Clinical Stage Pipeline Products 14

Phase II Products/Combination Treatment Modalities 14

Toray Industries, Inc. - Early Stage Pipeline Products 15

Preclinical Products/Combination Treatment Modalities 15

Discovery Products/Combination Treatment Modalities 16

Toray Industries, Inc. - Drug Profiles 17

beraprost sodium ER - Drug Profile 17

Product Description 17

Mechanism Of Action 17

R&D Progress 17

GT-0198 - Drug Profile 18

Product Description 18

Mechanism Of Action 18

R&D Progress 18

HIS-388 - Drug Profile 19

Product Description 19

Mechanism Of Action 19

R&D Progress 19

Small Molecule to Agonize Prostacyclin Receptor for Bleeding and Clotting Disorders - Drug Profile 20

Product Description 20

Mechanism Of Action 20

R&D Progress 20

Small Molecule to Antagonize Alpha1B Adrenoceptor - Drug Profile 21

Product Description 21

Mechanism Of Action 21

R&D Progress 21

Small Molecule to Antagonize CCR3 for Undisclosed Indication - Drug Profile 22

Product Description 22

Mechanism Of Action 22

R&D Progress 22

Small Molecule to Block TRPV1 for Overactive Bladder - Drug Profile 23

Product Description 23

Mechanism Of Action 23

R&D Progress 23

Small Molecule to Inhibit Soluble Epoxide Hydrolase for Chronic Kidney Disease - Drug Profile 24

Product Description 24

Mechanism Of Action 24